Skip to content

Efavirenz dose reduction safe for patients with gene associated with high drug levels and side-effects

Endothelial dysfunction in Italian cohort caused by HIV, not antiretrovirals, researchers conclude

Poorer responses to lipid-lowering drugs in people with HIV

Sweet sorrow: diabetes and HIV

Abacavir may increase blood coagulation risk

HIV infection has similar impact on hardening of arteries as smoking, diabetes

Rosiglitazone improves fat loss and insulin resistance in people with lipoatrophy

Diabetes, high blood pressure and smoking raise risk of death for all people with HIV

Certain protease inhibitors and abacavir linked to heart attacks in two large cohort studies